Evidence map›Paper›PMID 40282530›Full record

ArticleCancers2025

Association Between B-Cell Marker Expression and

Giby V George, Malgorzata Kajstura, Audrey N Jajosky, Hong Fang, Fatima Zahra Jelloul, Andrew G Evans, W Richard Burack, John M Bennett, L Jeffrey Medeiros, Wei Wang and 1 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giby V GeorgeLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0009-0007-9529-4564
Malgorzata KajsturaLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Audrey N JajoskyLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-8265-2496
Hong FangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-1780-5959
Fatima Zahra JelloulDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-3791-3204
Andrew G EvansLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
W Richard BurackLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-5584-584X
John M BennettLaboratory Medicine, Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
L Jeffrey MedeirosDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-6577-8006
Wei WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Siba El HusseinDepartment of Pathology, University of Vermont Larner College of Medicine, Burlington, VT 05401, USA.ORCID 0000-0002-1338-7107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) with

Indexed as

AMLAML-myelodysplasia-relatedB-cell expressionflow cytometry analysispDC-AMLplasmacytoid dendritic cell differentiationRUNX1RUNX1::RUNX1T1

Identifiers

PMID40282530
PMCPMC12026294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.